Chronic eosinophilic pneumonia
ICD-10 J82.81 is a billable code used to indicate a diagnosis of chronic eosinophilic pneumonia.
Chronic eosinophilic pneumonia (CEP) is a rare respiratory condition characterized by the accumulation of eosinophils in the lungs, leading to inflammation and damage to lung tissue. Clinically, patients often present with symptoms such as persistent cough, dyspnea, fever, and weight loss. The condition primarily affects the lower respiratory tract, particularly the alveoli, where eosinophilic infiltration occurs. Disease progression can vary; some patients may experience acute exacerbations, while others may have a more insidious onset. Diagnostic considerations include a thorough clinical history, imaging studies such as chest X-rays or CT scans showing bilateral infiltrates, and laboratory tests revealing elevated eosinophil counts in peripheral blood. A bronchoscopy with bronchoalveolar lavage may also be performed to confirm the diagnosis and rule out other conditions. Treatment typically involves corticosteroids to reduce inflammation and manage symptoms, with close monitoring for potential side effects. Long-term management may be necessary for chronic cases, emphasizing the importance of ongoing follow-up and patient education.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J82.81 specifically covers chronic eosinophilic pneumonia, which is characterized by eosinophilic infiltration in the lungs leading to respiratory symptoms. It is distinct from acute eosinophilic pneumonia and other eosinophilic lung diseases.
J82.81 should be used when a patient has a confirmed diagnosis of chronic eosinophilic pneumonia, particularly when eosinophilia is documented and other causes of respiratory symptoms have been ruled out.
Documentation should include clinical findings, imaging results showing lung infiltrates, laboratory tests indicating elevated eosinophil counts, and treatment plans. A comprehensive clinical history is also essential.
